TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Vascular Solutions, Inc. (NASDAQ:VASC) Investor Lawsuit Over Alleged Wrongdoing In Acquisition Announced

  • If you purchased shares of Vascular Solutions, Inc. (NASDAQ:VASC) and currently hold any of those NASDAQ:VASC shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
Vascular Solutions, Inc.
Security
NASDAQ: VASC

Case Name
Vascular Solutions Deal Case 02/03/2017
Type of Lawsuit
Mergers and Acquisition
You must register or login to receive notifications.

Click here to subscribe to Vascular Solutions, Inc..
Summary

February 3, 2017 (Shareholders Foundation) - An investor who currently holds shares of Vascular Solutions, Inc. (NASDAQ:VASC), filed a lawsuit in effort to halt the proposed takeover of Vascular Solutions, Inc. by Teleflex Incorporated for $56.00 per share.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:VASC stockholders by agreeing to sell Vascular Solutions, Inc. too cheaply via an unfair process to Teleflex Incorporated.

On December 2, 2016, Vascular Solutions, Inc. (Nasdaq: VASC) announced that it has entered into an agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56.00 per share in cash.

However, plaintiff claims that the proposed consideration NASDAQ:VASC shareholders will receive is grossly inadequate and undervalues Vascular Solutions, Inc. In addition, the plaintiff alleges that the process is also unfair NASDAQ:VASC stockholders. The plaintiff claims that the defendants agreed to preclusive deal protection devices, such as a no solicitation and a $35 million termination fee provision, that are detrimental to NASDAQ:VASC shareholders as they deter other bidders from making a superior offer for Vascular Solutions, Inc.